FDA Adverse Event Death Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2071925 · Received April 25, 2011

Report

Report Number
2017233-2011-00211
Event Type
Death
Date Received
April 25, 2011
Date of Event
March 29, 2011
Report Date
April 21, 2011
Manufacturer
W. L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MANUFACTURING PAPERWORK IS BEING CONDUCTED. THE REVIEW OF THE MANUFACTURING PAPERWORK HAS NOT BEEN COMPLETED. ADDITIONAL GORE EXCLUDER AAA DEVICES RELATED TO THIS EVENT: RMT311417/8777983, PXC141000/8602095. GORE DRYSEAL SHEATH ASSOCIATED WITH THIS EVENT: SDV2028/7703563 (REFER TO MANUFACTURER REPORT #2017233-2011-00212).

Description of Event or Problem · 1

ON (B)(6) 2011, THE PT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM AND WAS IMPLANTED WITH A GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING THE C3 DELIVERY SYSTEM AND TWO GORE EXCLUDER AAA CONTRALATERAL LEG ENDOPROSTHESES. THE DEVICES WERE PLACED WITHOUT INCIDENT. FINAL ANGIOGRAPHY SHOWED NO EVIDENCE OF AN ENDOLEAK. DIFFICULTIES WERE ENCOUNTERED AT THE END OF THE PROCEDURE WHEN THE GROINS WERE BEING CLOSED USING PERCUTANEOUS CLOSURE DEVICES. POST-OPERATIVELY, WITHIN AN HOUR, THE PT LOST PULSE IN ONE LEG DUE TO COMPLICATIONS ASSOCIATED WITH A FAILED PERCUTANEOUS CLOSURE. THE PT WAS TRANSFERRED TO THE OPERATING ROOM TO STOP THE BLEEDING AND SURGICALLY CLOSE THE GROIN. THE PT WAS STABILIZED. ON (B)(6) 2011, THE PT DIED. THE CAUSE OF DEATH WAS HEPATIC FAILURE, DISSEMINATED INTRAVASCULAR COAGULATION (DIC), KIDNEY FAILURE, AND CARDIOPULMONARY FAILURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES WLG425 8398632

Patients

Seq Age Sex Outcome Treatment
1 75 YR Death| H| L| R NORVASC| SIMVASTATIN| TRICOR| LISINOPRIL| ATENOLOL